Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations

Immune-related adverse events (irAEs) are side effects of immune checkpoint inhibitor therapy (ICI). While common irAEs have been well characterized, there are more limited data on rare immune related adverse events (RirAEs) due to low incidence. Lack of characterization of these entities has led to...

Full description

Bibliographic Details
Main Authors: Benjamin C. Park, Sathya Narayanan, Alexander Gavralidis, Fei Ye, Run Fan, Ryan J. Sullivan, Genevieve Boland, Kerry L Reynolds, Justin M. Balko, Matteo S. Carlino, Georgina V. Long, Leyre Zubiri, Alexander M. Menzies, Douglas B. Johnson
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:OncoImmunology
Subjects:
Immune checkpoint inhibitor toxicity
immune checkpoint inhibitors
immune related adverse events
melanoma
rare immune related adverse events
uncommon immune related adverse events
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2023.2188719

Internet

https://www.tandfonline.com/doi/10.1080/2162402X.2023.2188719

Similar Items